chr16-20418116-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_017888.3(ACSM5):āc.262A>Gā(p.Ile88Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_017888.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACSM5 | NM_017888.3 | c.262A>G | p.Ile88Val | missense_variant | 3/14 | ENST00000331849.8 | NP_060358.2 | |
ACSM5 | NM_001324372.2 | c.262A>G | p.Ile88Val | missense_variant | 3/14 | NP_001311301.1 | ||
ACSM5 | NM_001324371.2 | c.262A>G | p.Ile88Val | missense_variant | 3/14 | NP_001311300.1 | ||
ACSM5 | NM_001324373.2 | c.262A>G | p.Ile88Val | missense_variant | 3/4 | NP_001311302.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACSM5 | ENST00000331849.8 | c.262A>G | p.Ile88Val | missense_variant | 3/14 | 1 | NM_017888.3 | ENSP00000327916.4 | ||
ACSM5 | ENST00000575584.5 | c.262A>G | p.Ile88Val | missense_variant | 3/4 | 1 | ENSP00000460112.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152090Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461594Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727092
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152090Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74296
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at